Evidence map›Paper›PMID 32865116›Full record

ReviewJournal of the American Heart Association2020

Neurohormonal Regulation of I

Tyler Shugg, Andy Hudmon, Brian R Overholser

Open access · goldAbstract readReview
In one paragraph

Review in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Neurohumoral Activation in Heart Failure.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Modulation of IJournal of cellular physiology · 2022
    Article
  8. Article
  9. Neurohormonal Regulation of IJournal of the American Heart Association · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Tyler ShuggDivision of Clinical Pharmacology Indiana University School of Medicine Indianapolis IN.
Andy HudmonDepartment of Medicinal Chemistry and Molecular Pharmacology Purdue University College of Pharmacy West Lafayette IN.
Brian R OverholserDivision of Clinical Pharmacology Indiana University School of Medicine Indianapolis IN.
Indiana University School of MedicinePurdue University West Lafayette · USUniversity of Indianapolis · US

Funding

Regulation of KCNQ1 and KCNE1 Complex Formation during Sustained Beta-Adrenergic StimulationR03HL141619 · NHLBI · PURDUE UNIVERSITY · PI OVERHOLSER, BRIAN R · 2018 to 2019
$155k
NHLBI NIH HHS R03 HL141619
6 · The paper itself

Abstract

Heart failure (HF) results in sustained alterations in neurohormonal signaling, including enhanced signaling through the sympathetic nervous system and renin-angiotensin-aldosterone system pathways. While enhanced sympathetic nervous system and renin-angiotensin-aldosterone system activity initially help compensate for the failing myocardium, sustained signaling through these pathways ultimately contributes to HF pathophysiology. HF remains a leading cause of mortality, with arrhythmogenic sudden cardiac death comprising a common mechanism of HF-related death. The propensity for arrhythmia development in HF occurs secondary to cardiac electrical remodeling that involves pathological regulation of ventricular ion channels, including the slow component of the delayed rectifier potassium current, that contribute to action potential duration prolongation. To elucidate a mechanistic explanation for how HF-mediated electrical remodeling predisposes to arrhythmia development, a multitude of investigations have investigated the specific regulatory effects of HF-associated stimuli, including enhanced sympathetic nervous system and renin-angiotensin-aldosterone system signaling, on the slow component of the delayed rectifier potassium current. The objective of this review is to summarize the current knowledge related to the regulation of the slow component of the delayed rectifier potassium current in response to HF-associated stimuli, including the intracellular pathways involved and the specific regulatory mechanisms.

Indexed as

Death, Sudden, CardiacAnimalsArrhythmias, CardiacHeart FailureHumansNeurotransmitter AgentsPotassium ChannelsNeurotransmitter AgentsPotassium Channelsarrhythmiasheart failureIKsKCNQ1renin‐angiotensin‐aldosterone systemsympathetic nervous system

Identifiers

PMID32865116
PMCPMC7726975
OpenAlexW3082975063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.